ABSTRACT
The epithelial cell plays a key role in the transfer of radionuclides from lungs to blood following pulmonary exposure. The present study was designed to evaluate the transfer across human lung epithelial cells of various actinides (plutonium, americium and uranium), the influence of the physicochemical properties of plutonium compounds and of the chelating agent diethylene triamine pentaacetic acid (DTPA). To address this question, Calu-3 cells grown in a bicameral culture system were used. The integrity of the epithelial barrier was evaluated by measuring transepithelial electrical resistance (TEER) and the passage of a fluorescent marker, lucifer yellow. Activity measurement in basal compartment following periodic collection of culture medium was made from 2 h to seven days. To facilitate data handling and analysis, the statistical tool STATBIODIS was used. The results indicate differences in transfer for the different elements, and according to Pu physicochemical properties. Though to various extents, the chelating agent DTPA always increased the transfer of Pu and Am across the epithelial cells, without altering the integrity of the epithelial barrier. This in vitro cell culture model, by mimicking translocation of actinides from lungs to blood, can represent a valuable tool to further understand the underlying mechanisms and properties controlling this process.
Subject(s)
Actinoid Series Elements/pharmacology , Chelating Agents/pharmacology , Epithelial Cells/drug effects , Pentetic Acid/pharmacology , Actinoid Series Elements/chemistry , Actinoid Series Elements/toxicity , Biological Transport/drug effects , Cell Line, Tumor , Cell Membrane/drug effects , Cell Membrane/metabolism , Chelating Agents/chemistry , Chelating Agents/toxicity , Epithelial Cells/metabolism , Humans , L-Lactate Dehydrogenase/metabolism , Lung/cytology , Pentetic Acid/chemistry , Pentetic Acid/toxicityABSTRACT
The threat of a dirty bomb which could cause internal contamination has been of major concern for the past decades. Because of their high chemical toxicity and their presence in the nuclear fuel cycle, uranium and neptunium are two actinides of high interest. Calmodulin (CaM) which is a ubiquitous protein present in all eukaryotic cells and is involved in calcium-dependent signaling pathways has a known affinity for uranyl and neptunyl ions. The impact of the complexation of these actinides on the physiological response of the protein remains, however, largely unknown. An isothermal titration calorimetry (ITC) was developed to monitor in vitro the enzymatic activity of the phosphodiesterase enzyme which is known to be activated by CaM and calcium. This approach showed that addition of actinyl ions (AnO2n+), uranyl (UO22+) and neptunyl (NpO2+), resulted in a decrease of the enzymatic activity, due to the formation of CaM-actinide complexes, which inhibit the enzyme and alter its interaction with the substrate by direct interaction. Results from dynamic light scattering rationalized this result by showing that the CaM-actinyl complexes adopted a specific conformation different from that of the CaM-Ca2+ complex. The effect of actinides could be reversed using a hydroxypyridonate actinide decorporation agent (5-LIO(Me-3,2-HOPO)) in the experimental medium demonstrating its capacity to efficiently bind the actinides and restore the calcium-dependent enzyme activation.
Subject(s)
Actinoid Series Elements/chemistry , Calmodulin/metabolism , Cyclic Nucleotide Phosphodiesterases, Type 1/chemistry , Cyclic Nucleotide Phosphodiesterases, Type 1/metabolism , Actinoid Series Elements/pharmacology , Arabidopsis/drug effects , Arabidopsis/enzymology , Coordination Complexes/chemistry , Coordination Complexes/pharmacology , Enzyme Activation/drug effects , Ions/chemistry , Ions/pharmacology , Kinetics , Neptunium/chemistry , Protein Binding , Spectroscopy, Fourier Transform InfraredABSTRACT
The threat of a dirty bomb or other major radiological contamination presents a danger of large-scale radiation exposure of the population. Because major components of such contamination are likely to be actinides, actinide decorporation treatments that will reduce radiation exposure must be a priority. Current therapies for the treatment of radionuclide contamination are limited and extensive efforts must be dedicated to the development of therapeutic, orally bioavailable, actinide chelators for emergency medical use. Using a biomimetic approach based on the similar biochemical properties of plutonium(IV) and iron(III), siderophore-inspired multidentate hydroxypyridonate ligands have been designed and are unrivaled in terms of actinide-affinity, selectivity, and efficiency. A perspective on the preclinical development of two hydroxypyridonate actinide decorporation agents, 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO), is presented. The chemical syntheses of both candidate compounds have been optimized for scale-up. Baseline preparation and analytical methods suitable for manufacturing large amounts have been established. Both ligands show much higher actinide-removal efficacy than the currently approved agent, diethylenetriaminepentaacetic acid (DTPA), with different selectivity for the tested isotopes of plutonium, americium, uranium and neptunium. No toxicity is observed in cells derived from three different human tissue sources treated in vitro up to ligand concentrations of 1 mM, and both ligands were well tolerated in rats when orally administered daily at high doses (>100 micromol kg d) over 28 d under good laboratory practice guidelines. Both compounds are on an accelerated development pathway towards clinical use.
Subject(s)
Actinoid Series Elements/pharmacology , Biomimetic Materials/pharmacology , Chelating Agents/pharmacology , Decontamination/methods , Lithium/chemistry , Organometallic Compounds/pharmacology , Pyridones/pharmacology , Actinoid Series Elements/administration & dosage , Actinoid Series Elements/chemical synthesis , Actinoid Series Elements/chemistry , Administration, Oral , Biomimetic Materials/administration & dosage , Biomimetic Materials/chemical synthesis , Biomimetic Materials/chemistry , Cell Line/drug effects , Chelating Agents/administration & dosage , Chelating Agents/chemical synthesis , Chelating Agents/chemistry , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical/methods , Humans , Ligands , Organometallic Compounds/chemical synthesis , Organometallic Compounds/chemistry , Pentetic Acid/pharmacology , Pyridones/chemical synthesis , Pyridones/chemistry , Time FactorsABSTRACT
In case of accidental release of radionuclides into the environment, actinides represent a severe health risk to human beings following internal contamination (inhalation, ingestion or wound). For a better understanding of the actinide behaviour in man (in term of metabolism, retention, excretion) and in specific biological systems (organs, cells or biochemical pathways), it is of prime importance to have a good knowledge of the relevant actinide solution chemistry and biochemistry, in particular of the thermodynamic constants needed for computing actinide speciation. To a large extent, speciation governs bioavailability and toxicity of elements and has a significant impact on the mechanisms by which toxics accumulate in cell compartments and organs and by which elements are transferred and transported from cell to cell. From another viewpoint, speciation is the prerequisite for the design and success of potential decorporation therapies. The purpose of this review is to present the state of the art of actinide knowledge within biological media. It is also to discuss how actinide speciation can be determined or predicted and to highlight the areas where information is lacking with the aim to encourage new research efforts.
Subject(s)
Actinoid Series Elements/classification , Actinoid Series Elements/analysis , Actinoid Series Elements/pharmacology , Actinoid Series Elements/toxicity , Environmental Pollution , Humans , Radioisotopes/toxicity , ThermodynamicsABSTRACT
Bacteria may be beneficial for alleviating actinide contaminant migration through processes such as bioaccumulation or metal reduction. However, sites with radioactive contamination often contain multiple additional contaminants, including metals and organic chelators. Bacteria-based bioremediation requires that the microorganism functions in the presence of the target contaminant, as well as other contaminants. Here, we evaluate the toxicity of actinides, metals and chelators to two different bacteria proposed for use in radionuclide bioremediation, Deinococcus radiodurans and Pseudomonas putida, and the toxicity of Pu(VI) to Shewanella putrefaciens. Growth of D. radiodurans was inhibited at metal concentrations ranging from 1.8 microM Cd(II) to 32 mM Fe(III). Growth of P. putida was inhibited at metal concentrations ranging from 50 microM Ni(II) to 240 mM Fe(III). Actinides inhibited growth at mM concentrations: chelated Pu(IV), U(VI) and Np(V) inhibit D. radiodurans growth at 5.2, 2.5 and 2.1 mM respectively. Chelated U(VI) inhibits P. putida growth at 1.7 mM, while 3.6 mM chelated Pu(IV) inhibits growth only slightly. Pu(VI) inhibits S. putrefaciens growth at 6 mM. These results indicate that actinide toxicity is primarily chemical (not radiological), and that radiation resistance does not ensure radionuclide tolerance. This study also shows that Pu is less toxic than U and that actinides are less toxic than other types of metals, which suggests that actinide toxicity will not impede bioremediation using naturally occurring bacteria.
Subject(s)
Actinoid Series Elements/toxicity , Chelating Agents/toxicity , Deinococcus/drug effects , Pseudomonas putida/drug effects , Radioisotopes/toxicity , Shewanella putrefaciens/drug effects , Actinoid Series Elements/metabolism , Actinoid Series Elements/pharmacology , Biodegradation, Environmental , Chelating Agents/metabolism , Chelating Agents/pharmacology , Deinococcus/growth & development , Deinococcus/metabolism , Microbial Sensitivity Tests/methods , Plutonium/metabolism , Plutonium/pharmacology , Plutonium/toxicity , Pseudomonas putida/growth & development , Pseudomonas putida/metabolism , Radioactive Pollutants/metabolism , Radioisotopes/metabolism , Radioisotopes/pharmacology , Shewanella putrefaciens/growth & development , Shewanella putrefaciens/metabolismABSTRACT
PURPOSE: To compare the incidence of each lung tumour type after inhalation exposure of rats to either NpO(2) or industrial PuO(2) aerosols, which have a similar size. MATERIALS AND METHODS: Male Sprague-Dawley rats were exposed once and followed during their whole life span. At the end of their life, the whole lungs were fixed, embedded and cut into thin sections for histological analysis. The presence of tumours was evaluated on three distinct levels of the lobes for phenotype determination to establish dose-effect relationships. RESULTS: In the range of lung doses studied (0.05 to more than 50 Gy), the general trend was an increased frequency of all types of tumours after inhalation exposure to neptunium compared with plutonium. The linearity of the lower part of the dose-effect relationships for all malignant lung tumours leads to the conclusion that NpO(2) is 3.3-fold more carcinogenic than PuO(2). CONCLUSIONS: According to a linear extrapolation of the data on malignant lung tumour incidence collected among all studies reported on actinide oxide carcinogenesis, the risk of lung tumour appears to vary over a factor of about 10 depending on the nature and/or size of the aerosol. This variation has to be taken into account for a realistic assessment of tumour risk.
Subject(s)
Lung Neoplasms/chemically induced , Lung/radiation effects , Neptunium , Plutonium , Actinoid Series Elements/pharmacology , Aerosols , Animals , Dose-Response Relationship, Radiation , Lung/metabolism , Lung/pathology , Lung Neoplasms/diagnosis , Male , Neptunium/toxicity , Oxides/metabolism , Phenotype , Plutonium/toxicity , Radiation Dosage , Rats , Rats, Sprague-Dawley , Risk Factors , Time FactorsABSTRACT
There are indications that alpha-particle-emitting bone-seekers such as plutonium or americium could enhance bone mass by suppressing bone resorption. To assess this possibility, this study calculates doses from alpha-particle emitters to the cells involved in trabecular bone turnover. Alpha-particle energy deposition in tissue from a bone surface source was calculated by Monte Carlo modeling. This was combined with bone surface cellular geometry to yield dose rates to cells during the remodeling cycle. Bone-resorbing osteoclasts receive on average 50 times the dose rate that bone-forming osteoblasts receive. Newly formed bone shields osteoblasts from alpha particles emitted by the buried deposit of alpha-particle emitters. However, at alpha-particle bone-seeking radionuclide intakes known to cause changes in remodeling (about 3700 Bq/kg body weight), the alpha-particle dose to osteoclasts corresponds to an extremely low rate of cell traversals (0.07% per cycle). It is therefore unlikely that perturbation of bone remodeling by alpha-particle bone-seeking radionuclides is directly caused by alpha-particle traversals of remodeling cells; some other indirect mechanism might be involved.
Subject(s)
Actinoid Series Elements/pharmacology , Alpha Particles/adverse effects , Bone Remodeling/radiation effects , Bone Resorption/prevention & control , Bone and Bones/radiation effects , Humans , Osteoclasts/radiation effects , Radiation DosageABSTRACT
The effects of inhaled alpha-emitting actinides on the alveolar macrophage (AM) population of the rodent lung are reviewed and, in particular, of the effects of 239PuO2 on murine AM. The effects discussed include changes the AM pool size, macrophage diameter, mobility, phagocytic competence, and enzyme content. Finally, similarities in the dose-response relationships for the induction of nuclear aberrations by alpha emitters and in the induction of lung tumors by the same materials are noted.